Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: CEREP

Market Cap 7.72Cr 8.95Cr 7.1Cr 6.68Cr 13Cr 844.23Cr 13Cr 84Cr 33Cr 414.33Cr 34Cr 33Cr 1.43TCr P/E 2024 *
-
P/E 2025 -
Enterprise Value 5.61Cr 6.51Cr 5.16Cr 4.86Cr 9.13Cr 614.12Cr 9.21Cr 61Cr 24Cr 301.4Cr 24Cr 24Cr 1.04TCr EV / Sales 2024
2.02x
EV / Sales 2025 1.67x
Free-Float
4.22%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer - 11/04/2024
Director TitleAgeSince
Chairman - 11/08/2023
Director/Board Member - 23/05/2024
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
-1.51%-1.28%-13.21%-11.53% 4.34TCr
+0.76%+9.42%+303.09%+540.82% 3.35TCr
-4.74%-6.31%+10.75%-20.99% 2.85TCr
-0.47%-0.35%+3.38%+31.20% 2.92TCr
+0.06%+4.36%+13.31%+21.11% 2.53TCr
-0.02%+10.18% - - 1.44TCr
-0.98%-1.86%+53.43%+106.06% 1.31TCr
-1.50%-4.29%+1.79%+2.63% 1.27TCr
+1.67%+1.35%+105.56%+81.16% 1.23TCr
Average -0.82%+1.33%+59.76%+93.81% 2.36TCr
Weighted average by Cap. -1.04%+1.35%+62.38%+105.56%

Financials

2024 2025
Net sales 4.05Cr 4.69Cr 3.72Cr 3.5Cr 6.58Cr 442.91Cr 6.64Cr 44Cr 17Cr 217.37Cr 18Cr 17Cr 751.99Cr 4.11Cr 4.76Cr 3.78Cr 3.56Cr 6.68Cr 449.6Cr 6.74Cr 45Cr 17Cr 220.65Cr 18Cr 17Cr 763.34Cr
Net income 71.55L 82.93L 65.78L 61.91L 1.16Cr 78Cr 1.17Cr 7.8Cr 3.03Cr 38Cr 3.11Cr 3.05Cr 132.88Cr 47.82L 55.44L 43.97L 41.39L 77.77L 52Cr 78.42L 5.21Cr 2.03Cr 26Cr 2.08Cr 2.04Cr 89Cr
Net Debt -1.73Cr -2Cr -1.59Cr -1.49Cr -2.81Cr -188.74Cr -2.83Cr -19Cr -7.32Cr -93Cr -7.51Cr -7.35Cr -320.44Cr -2.1Cr -2.44Cr -1.93Cr -1.82Cr -3.42Cr -230.11Cr -3.45Cr -23Cr -8.92Cr -112.93Cr -9.15Cr -8.96Cr -390.68Cr
Logo CEREP
Eurofins Cerep specializes in the pre-clinical research of drugs for the pharmaceutical industry. Export accounts for 88.2% of net sales.
Employees
-
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!